HealthStream, Inc.
NASDAQ:HSTMMedical - Healthcare Information Services
-$0.34 today
- Market cap
- $831.60M
- Beta
- 0.47
- P/E (TTM)
- 37.8
- EPS (TTM)
- $0.68
- Dividend yield
- 0.51%
Volume 0.38M
Average 0.25M
HSTM EBITDA Margin
EBITDA as a percentage of revenue.
HealthStream, Inc.NASDAQ: HSTM
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to 23.6%
EBITDA Margin was 23.6% in Q1 FY2026, up 1.8 pp from a year earlier. On a trailing-twelve-month basis it was 22.4%, up 0.1 pp year over year. Over 3 fiscal years it widened by 1.9 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 4 analysts of 20.1% for the fiscal year ending Dec 2026, down from 21.9% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 23.6%+6.2 pp QoQ
- Last fiscal yearDec 2025
- 21.9%-0.7 pp YoY
- LTMMar 2026
- 22.4%+0.1 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +1.8 pp | -2.2 pp | -4.0 pp |
| 1 year | -0.7 pp | -1.8 pp | -1.1 pp |
| 3 years | +1.9 pp | -5.4 pp | -7.3 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 21.9%
- Year-over-year change
- -0.7pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.9% | -0.7pp |
| FY2024 | 2024-12-31 | 22.6% | +1.3pp |
| FY2023 | 2023-12-31 | 21.4% | +1.3pp |
| FY2022 | 2022-12-31 | 20.1% | +2.7pp |
| FY2021 | 2021-12-31 | 17.4% | — |
EBITDA Margin vs competitors
How HSTM compares with its peers on the latest reported figures
- HSTM's LTM Mar 2026 EBITDA Margin of 22.4% is the 2nd highest of the 10 companies compared; the peer median is 2.9%.
- Its year-over-year change of +0.1 pp is the 6th highest of 10, against a peer median of +0.9 pp.
- Over three fiscal years its change of +1.9 pp compares with a peer median of +3.6 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 22.8% | +1.3 pp | +8.3 pp | |
| LTM Mar 2026 | 22.4% | +0.1 pp | +1.9 pp | |
| LTM Mar 2026 | 20.1% | -9.1 pp | -10.5 pp | |
| LTM Apr 2026 | 8.6% | +10.7 pp | +57.9 pp | |
| LTM Mar 2026 | 4.9% | +295.3 pp | -78.9 pp | |
| LTM Jun 2026 | 2.9% | +0.9 pp | +3.6 pp | |
| LTM Mar 2026 | -1.9% | -3.3 pp | +31.6 pp | |
| LTM Mar 2026 | -16.7% | -18.0 pp | -22.5 pp | |
| LTM Mar 2026 | -22.3% | +24.7 pp | +64.4 pp | |
| LTM Mar 2026 | -63.6% | -59.1 pp | -5.5 pp | |
| Peer median (excluding HSTM) | 2.9% | +0.9 pp | +3.6 pp | |
Competitors are the stored peer set for HSTM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 256.71M | 266.83M | 279.06M | 291.65M | 304.06M |
| Cost of Revenue | 91.03M | 91.14M | 95.02M | 97.94M | 107.21M |
| Gross Profit | 165.68M | 175.68M | 184.04M | 193.71M | 196.86M |
| Gross Margin | 64.5% | 65.8% | 65.9% | 66.4% | 64.7% |
| Research & Development | 41.66M | 44.28M | 45.54M | 48.89M | 50.98M |
| Selling, General & Admin | 79.15M | 81.01M | 81.41M | 82.29M | 82.16M |
| Operating Expenses | 157.62M | 163.23M | 168.02M | 172.42M | 176.62M |
| Depreciation & Amortization | 36.81M | 37.95M | 41.08M | 41.24M | 43.48M |
| EBITDA | 44.58M | 53.53M | 59.59M | 66.05M | 66.7M |
| EBITDA Margin | 17.4% | 20.1% | 21.4% | 22.6% | 21.9% |
| Operating Income | 8.06M | 12.45M | 16.02M | 21.29M | 20.24M |
| Operating Margin | 3.1% | 4.7% | 5.7% | 7.3% | 6.7% |
| Interest Income | 0 | 444K | 2.36M | 3.83M | 3.34M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (289K) | 3.14M | 2.49M | 3.52M | 2.98M |
| Income Before Tax | 7.77M | 15.59M | 18.51M | 24.8M | 23.22M |
| Pre-Tax Margin | 3.0% | 5.8% | 6.6% | 8.5% | 7.6% |
| Income Tax Expense | 1.92M | 3.49M | 3.3M | 4.8M | 4.88M |
| Net Income | 5.85M | 12.09M | 15.21M | 20.01M | 18.34M |
| Net Margin | 2.3% | 4.5% | 5.5% | 6.9% | 6.0% |
| EPS (Basic) | 0.19 | 0.39 | 0.50 | 0.66 | 0.61 |
| EPS (Diluted) | 0.18 | 0.39 | 0.50 | 0.66 | 0.61 |
| Weighted Avg Shares | 31.53M | 30.65M | 30.57M | 30.39M | 30.02M |
| Weighted Avg Shares (Diluted) | 31.62M | 30.72M | 30.67M | 30.54M | 30.14M |
HealthStream, Inc.
NASDAQ:HSTM
Intrinsic Alpha fair value
Locked
Current Price
$27.18
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.